214 related articles for article (PubMed ID: 17603844)
1. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
Yao ZQ; King E; Prayther D; Yin D; Moorman J
Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
[TBL] [Abstract][Full Text] [Related]
2. Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.
Frazier AD; Zhang CL; Ni L; Ma CJ; Zhang Y; Wu XY; Atia AN; Yao ZQ; Moorman JP
Viral Immunol; 2010 Oct; 23(5):487-95. PubMed ID: 20883163
[TBL] [Abstract][Full Text] [Related]
3. PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.
Xiao W; Jiang LF; Deng XZ; Zhu DY; Pei JP; Xu ML; Li BJ; Wang CJ; Zhang JH; Zhang Q; Zhou ZX; Ding WL; Xu XD; Yue M
Immunol Res; 2016 Apr; 64(2):412-23. PubMed ID: 26286967
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection.
Zhang Y; Ma CJ; Ni L; Zhang CL; Wu XY; Kumaraguru U; Li CF; Moorman JP; Yao ZQ
J Immunol; 2011 Mar; 186(5):3093-103. PubMed ID: 21263070
[TBL] [Abstract][Full Text] [Related]
6. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
[TBL] [Abstract][Full Text] [Related]
7. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
[TBL] [Abstract][Full Text] [Related]
8. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
10. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.
Radziewicz H; Ibegbu CC; Fernandez ML; Workowski KA; Obideen K; Wehbi M; Hanson HL; Steinberg JP; Masopust D; Wherry EJ; Altman JD; Rouse BT; Freeman GJ; Ahmed R; Grakoui A
J Virol; 2007 Mar; 81(6):2545-53. PubMed ID: 17182670
[TBL] [Abstract][Full Text] [Related]
11. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
Zhang Y; Ma CJ; Wang JM; Ji XJ; Wu XY; Jia ZS; Moorman JP; Yao ZQ
PLoS One; 2011; 6(5):e19664. PubMed ID: 21637332
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma.
Yao ZQ; Ni L; Zhang Y; Ma CJ; Zhang CL; Dong ZP; Frazier AD; Wu XY; Thayer P; Borthwick T; Chen XY; Moorman JP
Immunol Invest; 2011; 40(3):243-64. PubMed ID: 21291295
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus: immunosuppression by complement regulatory pathway.
Yao ZQ; Ray S; Eisen-Vandervelde A; Waggoner S; Hahn YS
Viral Immunol; 2001; 14(4):277-95. PubMed ID: 11792059
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
[TBL] [Abstract][Full Text] [Related]
15. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
Lukens JR; Cruise MW; Lassen MG; Hahn YS
J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
[TBL] [Abstract][Full Text] [Related]
16. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
[TBL] [Abstract][Full Text] [Related]
17. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.
Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; Parra-Cid T
World J Gastroenterol; 2009 Nov; 15(41):5129-40. PubMed ID: 19891011
[TBL] [Abstract][Full Text] [Related]
18. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
Kasprowicz V; Schulze Zur Wiesch J; Kuntzen T; Nolan BE; Longworth S; Berical A; Blum J; McMahon C; Reyor LL; Elias N; Kwok WW; McGovern BG; Freeman G; Chung RT; Klenerman P; Lewis-Ximenez L; Walker BD; Allen TM; Kim AY; Lauer GM
J Virol; 2008 Mar; 82(6):3154-60. PubMed ID: 18160439
[TBL] [Abstract][Full Text] [Related]
19. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
20. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
